Normunity Inc

Normunity Inc., located in New Haven, CT, is a pioneering biotechnology company focused on developing innovative anti-cancer therapies that target the critical interface between the immune system and tumors. By collaborating with the Lieping Chen lab at Yale, they are uncovering unique biological mechanisms that help tumors evade immune surveillance, leading to the discovery of new therapeutic targets.

Leveraging a proprietary discovery process, Normunity is advancing a pipeline of biologic medicines, including therapeutic antibodies and bispecific antibodies, aimed at addressing unmet needs in various solid tumors. The company's mission is to transform cancer treatment by uncovering and exploiting the tumor-specific characteristics that contribute to cancer resilience.

Generated from the website